Febuxostat Sandoz 80 mg film-coat. tabl.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ixtrih issa

Ingredjent attiv:

Febuxostat Hemihydrate 82,28 mg - Eq. Febuxostat 80 mg

Disponibbli minn:

Sandoz SA-NV

Kodiċi ATC:

M04AA03

INN (Isem Internazzjonali):

Febuxostat Hemihydrate

Dożaġġ:

80 mg

Għamla farmaċewtika:

Film-coated tablet

Kompożizzjoni:

Febuxostat Hemihydrate 82.28 mg

Rotta amministrattiva:

Oral use

Żona terapewtika:

Febuxostat

Sommarju tal-prodott:

CTI code: 514960-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-02 - Pack size: 28 - Commercialisation status: NO - FMD code: 07613421019990 - CNK code: 3906575 - Delivery mode: Medical prescription; CTI code: 514986-05 - Pack size: 84 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-03 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-04 - Pack size: 56 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-03 - Pack size: 42 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-05 - Pack size: 84 - Commercialisation status: YES - FMD code: 07613421019983 - CNK code: 3906567 - Delivery mode: Medical prescription; CTI code: 514986-02 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514960-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-06 - Pack size: 98 - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 514986-01 - Pack size: 14 - Commercialisation status: NO - Delivery mode: Medical prescription

L-istatus ta 'awtorizzazzjoni:

Commercialised: No

Data ta 'l-awtorizzazzjoni:

2017-08-24

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ġermaniż 08-03-2024
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Franċiż 08-03-2024
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Franċiż 08-03-2024
RMP RMP Franċiż 10-11-2022
DHPC DHPC Franċiż 14-12-2022
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Olandiż 08-03-2024
Karatteristiċi tal-prodott Karatteristiċi tal-prodott Olandiż 08-03-2024
RMP RMP Olandiż 10-11-2022
DHPC DHPC Olandiż 14-12-2022